Pill shows promise for curing Ebola in monkeys

A new study shows that a pill called Obeldesivir can cure Ebola in monkeys. This development may lead to more practical and affordable treatments for humans, differing from previous methods that require complex storage and administration. In the experiment, 80% of cynomolgus macaques and 100% of rhesus macaques survived after receiving Obeldesivir daily for ten days. The drug cleared the virus and helped develop antibodies without causing organ damage. Obeldesivir is a polymerase inhibitor, blocking an enzyme needed for the virus to replicate. It is currently being advanced to Phase 2 clinical trials for the Marburg virus, a relative of Ebola.